Company data
Gilead Sciences, Inc. employees and revenue per employee
GILD · Drug Manufacturers - General · $179.5B market cap
Gilead Sciences, Inc. had 17,000 employees at the end of fiscal Dec 2025, down 3.4% from a year earlier. Revenue for the year was $29.4B, up 2.4% from a year earlier, or $1.73M per employee. Revenue held up or grew while headcount stayed flat or fell.
Employees
17,000
-3.4% YoY
Revenue
$29.4B
+2.4% YoY
Revenue / employee
$1.73M
Peer median $1.17M
Rank in industry
1 of 9
Drug Manufacturers - General
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Hover a year for the numbers.
| Year ending | Employees | Revenue | Per employee | Staff YoY | Revenue YoY |
|---|---|---|---|---|---|
| Dec 2025 | 17,000 | $29.4B | $1.73M | -3.4% | +2.4% |
| Dec 2024 | 17,600 | $28.8B | $1.63M | -2.2% | +6.0% |
| Dec 2023 | 18,000 | $27.1B | $1.51M | +5.9% | -0.6% |
| Dec 2022 | 17,000 | $27.3B | $1.60M | +18.1% | -0.1% |
| Dec 2021 | 14,400 | $27.3B | $1.90M | +5.9% | +10.6% |
| Dec 2020 | 13,600 | $24.7B | $1.82M | +15.3% | +10.0% |
| Dec 2019 | 11,800 | $22.4B | $1.90M | +7.3% | +1.5% |
| Dec 2018 | 11,000 | $22.1B | $2.01M | +10.0% | -15.2% |
| Dec 2017 | 10,000 | $26.1B | $2.61M | +11.1% | -14.1% |
| Dec 2016 | 9,000 | $30.4B | $3.38M | — | — |
Open roles: we have not matched a verified job board for this company yet.
Gilead Sciences, Inc. against similar companies
The closest industry peers by revenue, from Drug Manufacturers - General.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| GILD Gilead Sciences, Inc. | 17,000 | $29.4B | $1.73M | Leaner |
| BMY Bristol-Myers Squibb Company | 32,500 | $48.2B | $1.48M | Contracting |
| BIIB Biogen Inc. | 7,500 | $9.81B | $1.31M | Leaner |
| LLY Eli Lilly and Company | 50,000 | $65.2B | $1.30M | Efficient growth |
| AMGN Amgen Inc. | 31,500 | $36.7B | $1.17M | Hiring ahead |
| ABBV AbbVie Inc. | 57,000 | $61.2B | $1.07M | Efficient growth |
| MRK Merck & Co., Inc. | 75,000 | $64.9B | $866K | Leaner |
| PFE Pfizer Inc. | 75,000 | $62.6B | $834K | Contracting |
| JNJ Johnson & Johnson | 138,200 | $94.2B | $682K | Efficient growth |
Questions about Gilead Sciences, Inc.
- How many employees does Gilead Sciences, Inc. have?
- Gilead Sciences, Inc. reported 17,000 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 24, 2026. That is down 3.4% from a year earlier.
- What is Gilead Sciences, Inc.'s revenue per employee?
- Gilead Sciences, Inc. brought in $29.4B of revenue in fiscal Dec 2025, which is $1.73M per employee. That ranks 1 of 9 companies we track in Drug Manufacturers - General, where the median is $1.17M.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare GILD with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in Gilead Sciences, Inc.'s annual reports (Form 10-K), latest filed February 24, 2026. This is data, not a recommendation to buy or sell GILD.